Bakertrexate 2.5 – Methotrexate
Methotrexate 2.5 mg
Exporter, Distributor Drop shipper to Russia, Brazil, Colombia, Latin America And East Asia
Bakertrexate 2.5 contains Methotrexate 2.5 mg, an antimetabolite and immunosuppressive medication used in the treatment of various cancers, autoimmune disorders, and inflammatory conditions. It works by interfering with cell growth and immune system activity, making it an important therapeutic option in oncology and disease management.
|
Contain |
Methotrexate 2.5 mg |
|---|---|
|
Strength |
2.5 mg |
|
Packaging |
10X10TAB |
|
Category |
Categories: Anit Cancer |
|
Manufacturer |
Baker & Davis Private Limited |
|
Brand |
Bakertrexate |
Product Overview
Bakertrexate 2.5 contains Methotrexate, a well-established antimetabolite medication widely used in oncology, immunology, and rheumatology. It plays a significant role in the treatment of certain cancers as well as various autoimmune and inflammatory disorders. Due to its proven therapeutic effectiveness and extensive clinical use, Methotrexate remains one of the most trusted medications in modern medical practice.
The medicine works by inhibiting the metabolism of folic acid, an essential component required for DNA synthesis and cellular replication. By slowing down the growth of rapidly dividing cells, Methotrexate helps manage specific malignancies while also regulating abnormal immune system activity associated with autoimmune diseases.
Bakertrexate 2.5 is commonly prescribed under medical supervision and is used across hospitals, specialty clinics, and healthcare institutions worldwide. Its versatility and broad therapeutic application make it an important component of comprehensive treatment strategies.
How It Works
Methotrexate inhibits the enzyme dihydrofolate reductase, reducing the availability of folic acid required for DNA synthesis and cell division. This action helps slow the growth of rapidly multiplying cells and suppresses excessive immune responses, contributing to its effectiveness in both cancer treatment and autoimmune disease management.
Therapeutic Applications
Bakertrexate 2.5 may be prescribed for:
- Acute Lymphoblastic Leukemia (ALL)
- Non-Hodgkin Lymphoma
- Osteosarcoma
- Breast Cancer
- Psoriasis
- Rheumatoid Arthritis
- Autoimmune Disorders
- Other conditions as determined by the treating physician
Key Benefits
- Well-established therapeutic profile.
- Used in oncology and autoimmune disease management.
- Supports comprehensive treatment protocols.
- Helps regulate abnormal immune responses.
- Trusted by healthcare professionals worldwide.
- Manufactured under stringent pharmaceutical quality standards.
Quality Commitment
Vinix Biopharma is committed to delivering high-quality pharmaceutical products that meet stringent safety and quality standards. Bakertrexate 2.5 is manufactured in controlled environments and undergoes rigorous quality testing to ensure consistency, reliability, and product integrity.
Storage Information
Store in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children.
Disclaimer
Bakertrexate 2.5 should be used only under the supervision of a qualified healthcare professional. Dosage and treatment duration should be determined by the treating physician based on the patient’s medical condition and therapeutic requirements.
